Pharma

Pharmacist wants to crowdfund $25K for OTC gel that stops a nosebleed in one minute

No more sitting with the school nurse, five Kleenex, head tilted back during recess. A startup with University of Wisconsin ties has launched a $25,000 Indiegogo campaign to bring over-the-counter nosebleed relief to patients with a topical gel that claims to stop the nosebleed in one minute. Greg Dockter, a pharmacist, founded ByzMed LLC because […]

No more sitting with the school nurse, five Kleenex, head tilted back during recess. A startup with University of Wisconsin ties has launched a $25,000 Indiegogo campaign to bring over-the-counter nosebleed relief to patients with a topical gel that claims to stop the nosebleed in one minute.

Greg Dockter, a pharmacist, founded ByzMed LLC because he endures frequent nosebleeds himself and when a patient’s nose started bleeding at his pharmacy, he could only offer help by handing them a tissue. The product, DrXNoze, consists of a disposable swab with “natural” ingredients that “will make the blood clot faster and ingredients that will balance the mucus production of the nasal membrane.” That swab is inserted into the nose and placed on the problem area while the patient pinches her nose for a minute. The company targets consumers who have hypertension, take blood thinners, have allergies, use nasal steroids and so on.

The product has been “formulated with the assistance of the University of Wisconsin-Pharmacy School’s Lenor Zeeh Pharmaceutical Experimentation Station,” according to the site. The company is testing to see whether this product could be used to prevent nosebleeds.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

The money will go toward final stability trials and product packaging. The product should be ready to launch in December 2013.